Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Inari Medical by Year
Inari Medical — Cumulative Registered Clinical Trials (studies)
Stryker Inari Medical: 18 in FY2025, up 38.5% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
18
Period ended Dec 31, 2025
Change on a year earlier
+38.5%
13 in FY2024
History
8 years
Since FY2018
Sources
1
NIH ClinicalTrials.gov Registry — Inari Medical
Where the FY2025 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inari Medical — Cumulative Registered Clinical Trials (studies) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18 | +38.5% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2024 | Dec 31, 2024 | 13 | +18.2% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2023 | Dec 31, 2023 | 11 | +37.5% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2022 | Dec 31, 2022 | 8 | +100.0% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2021 | Dec 31, 2021 | 4 | +33.3% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2020 | Dec 31, 2020 | 3 | 0.0% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2019 | Dec 31, 2019 | 3 | 0.0% | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
| FY2018 | Dec 31, 2018 | 3 | – | NIH ClinicalTrials.gov Registry — Inari Medical ↗ |
Cite this data
StockData. (2026). Stryker Inari Medical, annual FY2018–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-ct-cum
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.